Smitha Nair, MD | |
20 Expedition Trl, Ste 101, Gettysburg, PA 17325-8599 | |
(717) 420-2254 | |
(717) 334-5599 |
Full Name | Smitha Nair |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 20 Expedition Trl, Gettysburg, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124171038 | NPI | - | NPPES |
015529200 | Medicaid | MD | |
216038 | Other | PA | JOHNS HOPKINS |
113212 | Other | PA | GEISINGER |
1987747 | Other | PA | HIGHMARK BLUE SHIELD |
225492 | Other | PA | UNISON-WMG |
50072614 | Other | PA | CAPITAL BLUE CROSS-WMG |
9480099 | Other | PA | AETNA |
J840-0005 | Other | CAREFIRST MD BCBS HMO | |
913982 | Other | CAREFIRST MD BCBS | |
P17766 | Other | CAREFIRST MD BCBS POS | |
102041319 | Medicaid | PA | |
20069100 | Other | PA | AMERIHEALTH MERCY-WMG |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | D66537 (Maryland) | Secondary |
207Q00000X | Family Medicine | MD432406 (Pennsylvania) | Primary |
Entity Name | Signify Health Medical Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191216001523 |
News Archive
More than a dozen drugs are known to treat symptoms such as hallucinations, erratic behaviors, disordered thinking and emotional extremes associated with schizophrenia, bipolar disorder and other severe mental illnesses.
Researchers at Dublin City University and their project partners in the EU FP7 funded DEXLIFE project have found fresh evidence to explain the processes that occur in the body's cells leading to the onset of type2 diabetes.
New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Smitha Nair, MD 20 Expedition Trl, Ste 101, Gettysburg, PA 17325-8599 Ph: (717) 420-2254 | Smitha Nair, MD 20 Expedition Trl, Ste 101, Gettysburg, PA 17325-8599 Ph: (717) 420-2254 |
News Archive
More than a dozen drugs are known to treat symptoms such as hallucinations, erratic behaviors, disordered thinking and emotional extremes associated with schizophrenia, bipolar disorder and other severe mental illnesses.
Researchers at Dublin City University and their project partners in the EU FP7 funded DEXLIFE project have found fresh evidence to explain the processes that occur in the body's cells leading to the onset of type2 diabetes.
New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 8 days ago
Michael Jay Mcglaughlin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 125 Park Ave, Gettysburg, PA 17325 Phone: 717-321-3439 Fax: 717-334-5966 | |
Dr. Bruce Edgar Walther, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 Chambersburg Rd, Gettysburg, PA 17325 Phone: 717-373-4410 Fax: 717-337-0267 | |
Orville Glenn Mcbeth Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 Chambersburg Rd, Gettysburg, PA 17325 Phone: 717-337-4410 Fax: 717-337-0267 | |
Jon A Dubin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 S Washington St Ste 12, Gettysburg, PA 17325 Phone: 717-339-2875 Fax: 717-334-3921 | |
Douglas Edward Eyer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 S Washington St, Gettysburg, PA 17325 Phone: 717-334-2183 Fax: 717-334-5246 | |
Dr. Nora Olson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1311 Biglerville Rd, Gettysburg, PA 17325 Phone: 717-334-8165 Fax: 717-338-9070 |